Literature DB >> 9295823

Effect of extreme metabolic acidosis on oxygen delivery capacity of the blood--an in vitro investigation of changes in the oxyhemoglobin dissociation curve in blood with pH values of approximately 6.30.

H E Refsum1, H Opdahl, S Leraand.   

Abstract

OBJECTIVES: To determine the oxyhemoglobin dissociation curve in blood with pH of approximately 6.3 due to metabolic and superimposed respiratory acidosis, and to evaluate the oxygen delivery capacity of the blood under these circumstances.
DESIGN: In vitro study.
SETTING: A blood gas laboratory in a university institute for respiratory physiology.
SUBJECTS: Heparinized normal human blood.
INTERVENTIONS: The oxyhemoglobin dissociation curve was determined by measuring PO2, pH, PCO2, and hemoglobin oxygen saturation at 37 degrees C in mixtures of blood from two reservoirs, both prepared by titration with lactic acid to a pH of 6.3 during tonometry with gases containing 4.2% CO2 and high and low oxygen percentages, respectively. For determination of the effect of additional increases in PCO2, the reservoir blood thus produced was prepared by further tonometry with gases containing 12.8% CO2 and the same oxygen percentages.
MEASUREMENTS AND MAIN RESULTS: With the same degree of lactic acidosis (blood lactate concentration of 52 mmol/L), the position of the oxyhemoglobin dissociation curve was the same for blood with PCO2 of 30 torr (4 kPa) and pH of 6.295 and for blood with PCO2 of 90 torr (12 kPa) and pH of 6.165. During tonometry with a gas with PCO2 of 30 torr (4 kPa) and PO2 of 20 torr (2.7 kPa) and addition of increasing amounts of lactic acid, leading to a stepwise change in pH from 6.7 to 6.0, hemoglobin oxygen saturation decreased with decreasing pH from 6.7 to 6.4, but remained the same at a pH of between 6.4 and 6.0. The measured rightward shift of the oxyhemoglobin dissociation curve at such a low pH was clearly less pronounced than that calculated using commonly applied equations, in particular, at the lowest pH. The beneficial effects of the rightward shift of the oxyhemoglobin dissociation curve on the estimates of extractable oxygen at a given venous PO2 decrease with decreasing pH, and disappear rapidly when the Pao2 is reduced below normal.
CONCLUSIONS: The acidemia-induced rightward shift of the oxyhemoglobin dissociation curve does not increase further at a pH < 6.4, and is, at such extreme acidemia, less pronounced than calculated by the commonly used equations. To obtain optimal tissue oxygenation in patients with severe circulatory failure and extreme metabolic acidosis, Pao2 should be > 250 torr (> 33.3 kPa).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295823     DOI: 10.1097/00003246-199709000-00016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  The acidosis-induced right shift of the HbO₂ dissociation curve is maintained during erythrocyte storage.

Authors:  Helge Opdahl; Tævje A Strømme; Lise Jørgensen; Livia Bajelan; Hans E Heier
Journal:  Scand J Clin Lab Invest       Date:  2011-04-08       Impact factor: 1.713

Review 2.  Fluid Stewardship of Maintenance Intravenous Fluids.

Authors:  John R Carr; W Anthony Hawkins; Andrea Sikora Newsome; Susan E Smith; Clemmons Amber B; Christopher M Bland; Trisha N Branan
Journal:  J Pharm Pract       Date:  2021-04-08

Review 3.  Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function.

Authors:  Tuhin K Roy; Timothy W Secomb
Journal:  Microcirculation       Date:  2020-12-21       Impact factor: 2.679

4.  Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside.

Authors:  Antoine Kimmoun; Emmanuel Novy; Thomas Auchet; Nicolas Ducrocq; Bruno Levy
Journal:  Crit Care       Date:  2015-04-09       Impact factor: 9.097

5.  Estimating the best fraction of inspired oxygen for calculation of PaO2/FiO2 ratio in acute respiratory distress syndrome due to COVID-19 pneumonia.

Authors:  Leila Kadkhodai; Mahmoud Saghaei; Mohammadreza Habibzadeh; Babak Alikiaii; Seyed Jalal Hashemi
Journal:  J Res Med Sci       Date:  2022-05-30       Impact factor: 1.985

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.